NCT01338623View on ClinicalTrials.gov

Bioequivalence Study of Tansulosine 0,4 mg Capsule in Health Subjects -Fed State

PHASE4UnknownINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

April 30, 2011

Study Completion Date

May 31, 2011

Conditions

Hyperplasia Prostatic

Interventions

DRUG

Tansulosine

capsule 0,4 mg

Trial Locations (1)

85903-590

RECRUITING

Biocinese, Toledo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Biocinese

INDUSTRY